Ads

You May Also Like

CoLucid Pharmaceuticals Announces Initiation of Second Phase 3 Pivotal Trial of Lasmiditan in Migraine

First Patient Randomized in SPARTAN StudyTrial Being Conducted Under Special Protocol Assessment Agreement with ...

Vedantra Pharmaceuticals Names Gregory I. Berk President and Chief Medical Officer

CAMBRIDGE, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Vedantra Pharmaceuticals, Inc., an immunotherapy company ...

Rexahn Pharmaceuticals Receives New U.S. Patent for Supinoxin™

ROCKVILLE, Md., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a ...